Remove 2022 Remove Compounding Remove Vaccines
article thumbnail

Pharmaceutical microbiology: key developments 2022

European Pharmaceutical Review

This Q&A covers the key developments in pharmaceutical microbiology in 2022, featuring insight from pharmaceutical microbiology experts: Dr Tim Sandle, Head of Microbiology, Bio Products Laboratory Limited. Regulation, particularly Annex 1, was identified as a key focus for 2022.

Vaccines 128
article thumbnail

Rapid microbiology testing market growth expected 2022 to 2027

European Pharmaceutical Review

A report has predicted the rapid microbiology testing market size is estimated to grow at a compound annual growth rate (CAGR) of 9.31 percent between 2022 and 2027. The research includes historic market data from 2017 to 2021, using 2022 as the base year. According to the data, the market is forecasted to increase by $2,487.91

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Cancer vaccines: providing the edge in oncology

pharmaphorum

In this article, Ben Hargreaves looks into the promise of cancer vaccines and how this treatment modality may offer advantages over existing immunotherapies in the oncology sector. One area that is gathering increasing levels of interest is the development of cancer vaccines. over the last five years. A broad front.

Vaccines 134
article thumbnail

STAT+: Pharmalittle: We’re reading about compounders suing the FDA, Biogen turning to telehealth, and more

STAT

… A trade group representing large compounding pharmacies has sued the U.S. appeals court ruled 2-1 that Merck is immune from an antitrust lawsuit accusing it of misleading regulators about the effectiveness of its mumps vaccine in order to ward off competition, Reuters says. from 1967 until 2022. ” A U.S.

article thumbnail

2022 in review: Drug development milestones for tropical diseases

Pharmaceutical Technology

Pharmaceutical Technology lists some of the top events in the tropical disease arena in 2022. Novel therapeutics and vaccines for malaria. As per the WHO’s 2022 malaria report , 63,000 malaria deaths were attributed to Covid-19-caused disruptions to services from 2019–21.

Vaccines 105
article thumbnail

NCPA Annual Convention Exhibitor Recap 2022

DiversifyRx

Here are the 10 most exciting companies I saw at the 2022 NCPA annual convention. NCPA held its 2022 annual convention in Kansas City. Many people are curious to know if their antibody levels are high or low and how they change after a vaccine booster or a sickness. NCPA Annual Convention 2022 Wrap Up. Weight loss meds?

article thumbnail

Top biopharmaceutical Covid-19 vaccine companies boosted with over 80% revenue growth

Pharmaceutical Technology

Last year was a positive year for biopharmaceutical companies, particularly those with Covid-19 vaccines. As a result of huge global sales of mRNA Covid-19 vaccines, the split in profits between Pfizer and BioNTech’s Comirnaty contributed towards revenues of $81.3bn and $22.4bn last year, respectively. YoY revenue growth.

Vaccines 108